FORTIS CONSOLIDATED REVENUES FOR FY17 AT RS 4,574 CR, UP 8.7%
OPERATING EBITDA GROWS A ROBUST 75% TO RS 362 CR
HOSPITAL BUSINESS REVENUES FOR FY17 AT RS 3,712 CR, UP 8.3%
OPERATING EBITDA INCREASES 3.6x TO RS 173 CR
SRL NET REVENUES FOR FY17 AT RS 795 CR, UP 10.6%
OPERATING EBITDA AT RS 175 CR, 21.9% MARGINS
CONSOLIDATED REVENUES FOR Q4FY17 AT RS 1,123 CR, UP 5%
OPERATING EBITDA UP 79% AT RS 84 CR
HOSPITAL BUSINESS REVENUES FOR Q4 AT RS 913 CR, UP 5%; OPERATING EBITDA UP 2.8x TO RS 46 CR
SRL NET REVENUES AT RS 203 CR, UP 12.3%; OPERATING EBITDA AT RS 40 CR, 19.9% MARGINS
Fortis Healthcare Ltd. (Fortis), India’s leading healthcare delivery Company, today, announced its consolidated results for the quarter and year ended March 31, 2017 (Q4FY17 and FY17).
Consolidated Business - Key Financial Highlights for the year (FY17)
*EBITDAC refers to EBITDA before net business trust costs